ARCHIVES

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Healthy Weight, Lower Stress May Result In Fewer Changes Associated With Aging

March 27, 2009

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

AACI’s “12 Tasks” Outlined to Board

March 28, 1975

Arnold Levine Named Professor At UMDNJ

February 28, 2003

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974